Navigation Links
Regado Biosciences, Inc. to Present at the Sofinnova Japan Biopharma Partnering Conference in Tokyo, Japan
Date:9/28/2011

BASKING RIDGE, N.J., Sept. 28, 2011 /PRNewswire/ -- Regado Biosciences, Inc., a privately held company leading the development of antithrombotic aptamers with active control agents, announced that David J. Mazzo, PhD, President and CEO, will be presenting at the Sofinnova Japan Biopharma Partnering Conference at 2:50 p.m. JST on October 4, 2011 in Tokyo, Japan.

The presentation will include an overview of the Company's pipeline with emphasis on the lead development program, the innovative anticoagulant system REG1, including a summary of the REG1 phase 2b trial (RADAR) results.

The Sofinnova Japan Biopharma Partnering Conference connects premier biotechnology companies from North America and Europe with Japanese licensing and business development executives.

ABOUT REGADO BIOSCIENCES

Regado Biosciences, Inc. is a private biopharmaceutical company pioneering a new therapeutic technology with the creation and development of proprietary controllable aptamer drug systems.  Each system comprises a nuclease-stabilized RNA aptamer, the therapeutic effect of which can be reversed partially or completely in real time by its specific and complementary oligonucleotide active control agent. This technology is being applied to injectable antithrombotics (including anticoagulants and antiplatelet agents) in the acute and sub-acute care cardiovascular setting, a multi-billion dollar world-wide market in need of drugs with improved safety profiles and a greater degree of therapeutic control.  The products in Regado's pipeline are designed to act as optimized antithrombotics, uniquely and concomitantly minimizing the risk of ischemia and bleeding, and, by allowing patient specific tuning of the desired therapeutic effect, provide a safe and unique approach to personalized medicine.

ABOUT REG1, REG2 and REG3  

Regado's lead program, the anticoagulant system REG1, consists of two agents both adminis
'/>"/>

SOURCE Regado Biosciences, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Regado Biosciences to Present at the Annual UBS Global Life Sciences Conference in New York City
2. Regado Biosciences, Inc. Presents Results of the RADAR Phase 2b Clinical Trial of its REG1 Anticoagulation System
3. Regado Biosciences to Present at the Needham & Companys 10th Annual Healthcare Conference in New York City
4. Regado Biosciences, Inc. Announces Presentation of the Results of the RADAR Phase 2b Clinical Trial of Its Anticoagulant System REG1 at the i2 Summit During the American College of Cardiology 2011 60th Annual Scientific Session & Expo in New Orleans
5. Regado Biosciences to Present at the 2011 RBC Capital Markets Healthcare Conference in New York City
6. Regado Biosciences, Inc. Introduces REG3, a Novel Aptamer-Based Inhibitor of Glycoprotein VI and its Matched Active Control Agent, at the American Heart Association (AHA) Scientific Sessions 2010 Meeting
7. Regado Biosciences, Inc. Presents Pharmacokinetic and Pharmacodynamic (PK/PD) Substudy Results From its Phase 2b RADAR Trial at the American Heart Association (AHA) Scientific Sessions 2010 Meeting
8. Regado Biosciences, Inc. Presents Two Abstracts on the Subcutaneous Depot Formulation of Pegnivacogin, a Nuclease-Stabilized RNA Aptamer, Direct Factor IXa Inhibitor and Part of the REG2 Anticoagulant System, at the American Heart Association (AHA)
9. Regado Biosciences to Present at the IMPACT 2010 Conference in Philadelphia, Pennsylvania
10. Regado Biosciences, Inc. Presents the First-In-Human Clinical Experience with REG2 at the American College of Chest Physicians (ACCP) Coagulation and Heart Disease Sessions in Vancouver, BC, Canada on November 2, 2010
11. Regado Biosciences to Present at the Stifel Nicolaus Healthcare Conference 2010 on September 16, 2010 in Boston, Massachusetts
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/1/2015)... 2015 The latest clinical ... trials review of H2, 2015 provides an overview ... to enhance decision making capabilities of active stakeholders ... Keratoconus market clinical trials review spread across 72 ... government organizations and supported with 43 tables and ...
(Date:9/1/2015)... OAKS, Calif. , Sept. 1, 2015 /PRNewswire/ ... neuroscience collaboration with Novartis in the areas of ... potential entry into Alzheimer,s disease by teaming up ... Alzheimer,s disease program directed at genetically predisposed individuals ... enables Amgen to focus on the commercialization of ...
(Date:9/1/2015)... PARK, Calif. , Sept. 1, 2015 ... device company that is providing innovative evidence-based solutions for ... company has submitted its preliminary response to the Patent ... petitions for inter partes review (IPR), filed by ... of certain claims in U.S. Patent No. 8,359,102 (the ...
Breaking Medicine Technology:Keratoconus Market Clinical Trials Review H2 2015 Global Research Report 2Keratoconus Market Clinical Trials Review H2 2015 Global Research Report 3Keratoconus Market Clinical Trials Review H2 2015 Global Research Report 4Keratoconus Market Clinical Trials Review H2 2015 Global Research Report 5Amgen Enters Into Neuroscience Collaboration With Novartis For Alzheimer's Disease And Migraine Programs 2Amgen Enters Into Neuroscience Collaboration With Novartis For Alzheimer's Disease And Migraine Programs 3Amgen Enters Into Neuroscience Collaboration With Novartis For Alzheimer's Disease And Migraine Programs 4Amgen Enters Into Neuroscience Collaboration With Novartis For Alzheimer's Disease And Migraine Programs 5Amgen Enters Into Neuroscience Collaboration With Novartis For Alzheimer's Disease And Migraine Programs 6Amgen Enters Into Neuroscience Collaboration With Novartis For Alzheimer's Disease And Migraine Programs 7Amgen Enters Into Neuroscience Collaboration With Novartis For Alzheimer's Disease And Migraine Programs 8Amgen Enters Into Neuroscience Collaboration With Novartis For Alzheimer's Disease And Migraine Programs 9Nevro Announces Submission of Preliminary Response to the Patent Trial and Appeals Board 2
... Reportlinker.com announces that a new market research ...   Global Ophthalmic Lasers ...   The global outlook series on ... market briefs, and concise summaries of research findings. ...
... (NASDAQ: ARNA ) today announced that ... results after the NASDAQ Global Select Market closes on Wednesday, ... Executive Officer, Jack Lief, will host a conference call at ... the financial results for the fourth quarter and full year ...
Cached Medicine Technology:Global Ophthalmic Lasers Industry 2Global Ophthalmic Lasers Industry 3Global Ophthalmic Lasers Industry 4Global Ophthalmic Lasers Industry 5Arena Pharmaceuticals to Host Business and Financial Update Conference Call and Webcast on Wednesday, March 14 2Arena Pharmaceuticals to Host Business and Financial Update Conference Call and Webcast on Wednesday, March 14 3
(Date:9/2/2015)... ... September 02, 2015 , ... The ... provide two days of payroll education covering legislative updates, including unemployment, global payroll ... which include representatives from Ceridian, Ultimate Software, the American Payroll Association, Barnett Associates, ...
(Date:9/2/2015)... IL (PRWEB) , ... September 02, 2015 , ... ... off ahead of Breast Cancer Awareness Month (BCAM), Bright Pink, a national non-profit ... young women, will launch Act On Facts, a campaign to educate women to ...
(Date:9/1/2015)... Minneapolis-St. Paul- Eagan (PRWEB) , ... September 01, 2015 , ... For many men, the ... double chin. Men were often forced to wear a looser fitting shirt with a ... adjusting their neck, sliding a finger between their collar and skin all day because it’s ...
(Date:9/1/2015)... ... September 01, 2015 , ... Earth Brands, ... new fall collection. Every customer who buys an Earth Brand shoe will be ... partnership with Trees for the Future, a nonprofit dedicated to planting more trees. ...
(Date:9/1/2015)... ... ... Celebrity hairstylist and Beauty Gives Back Art Team member Ted Gibson in ... Oct. 1, at the La Valencia Hotel. The presentation, on the eve of Fashion ... professional hair, makeup and nail design. , The evening of beauty and fashion ...
Breaking Medicine News(10 mins):Health News:23rd Annual NJ Statewide Payroll Conference in Vernon, NJ at the Minerals Hotel on October 15-16, 2015 2Health News:Bright Pink Launches Act On Facts™, A Campaign To Empower Young Women To Take Action Related To Their Breast And Ovarian Health 2Health News:Bright Pink Launches Act On Facts™, A Campaign To Empower Young Women To Take Action Related To Their Breast And Ovarian Health 3Health News:Getting Rid of Double Chins: New FDA Approved Kybella Treatment Proving Very Popular Among Professional Men at Crutchfield Dermatology 2Health News:Earth Brands Footwear Partners with Trees for the Future for Launch of Fall Collection: Buy Shoes, Plant a Tree 2Health News:Earth Brands Footwear Partners with Trees for the Future for Launch of Fall Collection: Buy Shoes, Plant a Tree 3Health News:Celebrity Hairstylist Ted Gibson Explores Fusion of Fashion and Beauty at “Beauty Behind the Fashion” at Fashion Week San Diego Proceeds to benefit THIRST Project 2Health News:Celebrity Hairstylist Ted Gibson Explores Fusion of Fashion and Beauty at “Beauty Behind the Fashion” at Fashion Week San Diego Proceeds to benefit THIRST Project 3
... Inc.,(Nasdaq: TRBN ) today announced that Scott ... president and chief medical officer (CMO).,Dr. Stromatt replaces ... his,position with the company for personal reasons in ... experience related to the development and,commercialization of novel ...
... say aim is to generate awareness of the problem , , ... less likely to be transported to an official trauma center ... , The finding was based on a review of a ... And it suggests that the difference in care first comes ...
... (ECI - HC Innovations, Inc., OTC Bulletin Board: ... year contract with HIP Health Plans of,New York ... into,Medical Homes. The contract is part of the ... care for health plan members by,developing a high ...
... Text-Related Injuries on the Rise, ATLANTA, Aug. ... issued new guidelines to help mobile,users practice ,safe ... text-related,accidents., With more than 363 billion text ... there is growing concern over individuals who text ...
... From Teleflora Support Cancer ... ... Teleflora, the world,s leading,floral service offering only hand-arranged, hand-delivered ... a,partnership with Stand Up To Cancer (SU2C) a new initiative ...
... Solutions to Speed Up Vision Plan Provider,s Payment ... Claim Processes, Improves Operational Efficiency, ... /PRNewswire-FirstCall/,-- Autonomy Corporation plc (LSE: AU. or AU.L), ... today announced that General,Vision Services (GVS) has selected ...
Cached Medicine News:Health News:Trubion Pharmaceuticals Announces Appointment of New Chief Medical Officer 2Health News:Trubion Pharmaceuticals Announces Appointment of New Chief Medical Officer 3Health News:Older Patients Less Likely to Be Taken to Trauma Centers 2Health News:Older Patients Less Likely to Be Taken to Trauma Centers 3Health News:Enhanced Care Initiatives (HC Innovations, Inc.) Contracts with HIP and GHI to Create a Medical Home Network Project with Support from the Commonwealth Fund 2Health News:Enhanced Care Initiatives (HC Innovations, Inc.) Contracts with HIP and GHI to Create a Medical Home Network Project with Support from the Commonwealth Fund 3Health News:Enhanced Care Initiatives (HC Innovations, Inc.) Contracts with HIP and GHI to Create a Medical Home Network Project with Support from the Commonwealth Fund 4Health News:SpinVox Offers New Guidelines to Help Users Practice 'Safe Text' 2Health News:SpinVox Offers New Guidelines to Help Users Practice 'Safe Text' 3Health News:Teleflora and Stand Up To Cancer Join Forces 2Health News:Teleflora and Stand Up To Cancer Join Forces 3Health News:General Vision Services Standardizes on Autonomy to Automate Third-Party Administration Processes for Vision Care Services 2Health News:General Vision Services Standardizes on Autonomy to Automate Third-Party Administration Processes for Vision Care Services 3Health News:General Vision Services Standardizes on Autonomy to Automate Third-Party Administration Processes for Vision Care Services 4
... The Arrow LionHeart Left Ventricular Assist ... is designed to be used as a ... end-stage (Class IV) congestive heart failure, for ... The Arrow LionHeart LVAS is not intended ...
... VAD System includes three major components: Blood ... TLC-II Portable Driver. This system provides partial ... heart, with conventional therapy, is unable to ... To accomplish support, blood flows from the ...
Datascope presents a unique new product for post-hemostasis puncture site management. Safeguard is the first product ever to combine a built-in inflatable bulb and a sterile dressing- providing adjus...
... The Cool Line catheter is inserted into ... in the superior vena cava. The ... which have sterile, temperature-controlled saline flowing within ... with the central circulation. The Cool ...
Medicine Products: